The Straits Times
AsiaPac · 2 hrs ago
✦ 78◉ Centre
Experimental pancreatic cancer pill doubles survival chances, boosts quality of life
78Quality
0Ratings
0Comments
AI Analysis
Quality 78/100
Partisan intensity 35/100
ObjectivePartisan
◉ Centre ✓ Fair headline
An experimental pancreatic cancer drug called daraxonrasib showed a 60 per cent reduction in death risk compared to chemotherapy in clinical trials, potentially improving survival outcomes and quality of life for patients.
Experimental pancreatic cancer pill doubles survival chances, boosts quality of life
Daraxonrasib reduced the overall risk of death by 60 per cent compared with chemotherapy.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!